Biosimilar Market Research Reports

"...... ation and industry data. Data were collected from the Oncology Biosimilars companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house datab......"

"...... ies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are offi......"

"...... ent factors that aid the market growth. Segment by Type - Monoclonal Antibodies - Interferon - Erythropoietin - Insulin - Vaccines - Others Segment by Application - Tumor......"

"...... o develop more biosimilar drugs. Additionally, Biosimilars are priced way lower than their reference counterparts, with the increasing burden of health expenditure. Biosimilars provide relief to the healthcare infrastructure of several......"

"...... ent factors that aid the market growth. Segment by Type Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Recombinant Glycosylated Proteins Segment by Application Oncology Bloo......"

"...... le environment. However, the market growth is expected to be restrained by complexities in manufacturing, excess competition and complexities in pricing. The US biosimilar market by drug class can be segmented as follows: monoclonal antibodie......"

"...... tis (Sandoz), Dr Reddy's, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biosimilar Monoclonal Antibodies from 2......"

"...... s on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Oncology Biosimilars market size by players, by Type and by Application, for the period 20......"

"...... from 2017 to 2027. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included such as United States, China, Japan, India, ......"

"...... orecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Biosimilars market size by players, by Type and by Application, for the period 2017-2028. The key players in......"